Positive results from COLCORONA trial suggest colchicine reduces risk of COVID-19-related complications

Preliminary results (n=4488) demonstrated colchicine reduced risk of death or hospitalisations by 21% vs placebo. Analysis (n=4159 with positive PCR test) demonstrated a reduction of hospitalisations by 25%, requirement for ventilation by 50%, and mortality by 44% vs placebo.

Source:

Biospace Inc.